Significant Revenue Growth
Net revenue of $770 million, representing growth of greater than 14% over the prior year quarter. Adjusted EBITDA grew 22% to $128.6 million with a margin of 16.7%, expanding 100 basis points compared to the prior year quarter.
Increase in Total Joint Replacements
Total joint replacements in ASCs increased 53% in the quarter, with a 5-year CAGR greater than 80%.
Strong Physician Recruitment
Over 230 new physicians started utilizing facilities in the third quarter, bringing total recruits for the first 3 quarters of the year to just over 640.
M&A Expansion in Key Markets
Deployed $24 million on five end market transactions, including acquisitions in New York, Texas, and Chicago, with a focus on high-growth markets.
Solid Cash Position and Liquidity
Ended the quarter with $222 million in cash and over $815 million in total liquidity.